Kleanthis Gabriel Xanthopoulos
CIK: 0002115875
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CNTB
Connect Biopharma Holdings Ltd
Director
Discretionary Trading P&L
Holdings
About Xanthopoulos Kleanthis Gabriel
Xanthopoulos Kleanthis Gabriel (SEC CIK 0002115875) files insider reports with the SEC as Director of Connect Biopharma Holdings Ltd (CNTB).
Signal8 holds 4 ownership filings by Xanthopoulos Kleanthis Gabriel (1 Form 3, 3 Form 4), filed between Mar 16, 2026 and Oct 1, 2026. Those filings report 3 transactions, from Mar 31, 2026 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Xanthopoulos Kleanthis Gabriel's filings is in SAN DIEGO, CA.
Recent filings by Xanthopoulos Kleanthis Gabriel
Other insiders filing for Connect Biopharma Holdings Ltd (CNTB)
- LIU JEAN I, Director
- Huang James, Director
- Szekeres David Leslie, President
- Quart Barry D, Chief Executive Officer
- Peraza Lisa, Senior Vice President, Finance
- WILSON KAREN J, Director